Basel, Switzerland

Vincent Mauduit

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Roche Molecular Systems, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vincent Mauduit: Innovator in Medical Data Verification

Introduction

Vincent Mauduit is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medical technology, particularly in the area of machine learning applications for healthcare.

Latest Patents

Vincent Mauduit holds a patent for a "Machine learning based medical data checker." This innovative method proposes a way to verify multi-modal medical data. The process involves accessing multi-modal medical data of a subject, which includes a medical image of a specimen slide. The method generates predictions regarding biological attributes of the medical image and assesses the consistency between these attributes and other modalities of the medical data. Ultimately, it provides an indication of any inconsistencies present in the multi-modal medical data.

Career Highlights

Vincent Mauduit is currently employed at Roche Molecular Systems, Inc., where he applies his expertise in medical data verification. His work focuses on enhancing the accuracy and reliability of medical data through advanced machine learning techniques.

Collaborations

Some of his notable coworkers include Benjamin Torben-Nielsen and Fernando Garcia-Alcalde, who contribute to the innovative environment at Roche Molecular Systems.

Conclusion

Vincent Mauduit's work in machine learning and medical data verification represents a significant advancement in healthcare technology. His contributions are paving the way for more reliable medical data analysis and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…